Table: SymBio Pharmaceuticals - 6-MTH group results

SymBio Pharmaceuticals

03/08/2023 07:30

Aug 3 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to  
                  Jun 30, 2023        Jun 30, 2022      Dec 31, 2023 
                     LATEST             YEAR-AGO           LATEST    
                     RESULTS             RESULTS          FORECAST   
  Sales               3.18                4.87              6.48     
                   (-34.8 pct)                          (-35.3 pct)  
  Operating        loss 49 mln            1.37          loss 331 mln 
  Recurring          66 mln               1.45          loss 219 mln 
                   (-95.4 pct)                                       
  Net              loss 79 mln            1.11          loss 370 mln 
  EPS             loss 2.02 yen         28.71 yen      loss 9.34 yen 
  EPS Diluted                           28.32 yen                    
  Ann Div                                  NIL              NIL      
  -Q2 div              NIL                 NIL                       
  -Q4 div                                  NIL              NIL      
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T